Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study (Q37582317)
Jump to navigation
Jump to search
scientific article published on 16 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study |
scientific article published on 16 September 2013 |
Statements
1 reference
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study (English)
1 reference
Flossie Wong-Staal
1 reference
David Wyles
1 reference
Mark S Sulkowski
1 reference
Gene D Morse
1 reference
Minhee Kang
1 reference
Roy Matining
1 reference
Victoria A Johnson
1 reference
Valerianna Amorosa
1 reference
Debika Bhattacharya
1 reference
Kristine Coughlin
1 reference
Marshall J Glesby
1 reference
AIDS Clinical Trials Group A5277 Protocol Team
1 reference
16 September 2013
1 reference
1 reference
Identifiers
1 reference